These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Carboxyfluorescein (CFSE) labelling of hepatocytes for short-term localization following intraportal transplantation. Fujioka H; Hunt PJ; Rozga J; Wu GD; Cramer DV; Demetriou AA; Moscioni AD Cell Transplant; 1994; 3(5):397-408. PubMed ID: 7827777 [TBL] [Abstract][Full Text] [Related]
45. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Dufrane D; Steenberghe Mv; Goebbels RM; Saliez A; Guiot Y; Gianello P Biomaterials; 2006 Jun; 27(17):3201-8. PubMed ID: 16497373 [TBL] [Abstract][Full Text] [Related]
46. Repopulation of the immunosuppressed retrorsine-treated infant rat liver with human hepatocytes. Tachibana A; Tateno C; Yoshizato K Xenotransplantation; 2013; 20(4):227-38. PubMed ID: 23683097 [TBL] [Abstract][Full Text] [Related]
47. Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Mei J; Sgroi A; Mai G; Baertschiger R; Gonelle-Gispert C; Serre-Beinier V; Morel P; Bühler LH Cell Transplant; 2009; 18(1):101-10. PubMed ID: 19476213 [TBL] [Abstract][Full Text] [Related]
49. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Mai G; Huy NT; Morel P; Mei J; Bosco D; Berney T; Majno P; Mentha G; Trono D; Buhler LH Transplant Proc; 2005; 37(1):527-9. PubMed ID: 15808699 [TBL] [Abstract][Full Text] [Related]
50. Gastric submucosa as the safer and repeatable site for hepatocyte transplantation. Kakihara N; Takeshita K; Naka S; Ishibashi H Transplant Proc; 2009; 41(1):425-8. PubMed ID: 19249571 [TBL] [Abstract][Full Text] [Related]
51. Bioartificial pancreas containing porcine islets of Langerhans implanted in low-dose streptozotocin-induced diabetic mice: effect of encapsulation medium. Delaunay C; Honiger J; Darquy S; Capron F; Reach G Diabetes Metab; 1997 Jun; 23(3):219-27. PubMed ID: 9233999 [TBL] [Abstract][Full Text] [Related]
52. Transplantation of encapsulated bovine chromaffin cells in the sheep subarachnoid space: a preclinical study for the treatment of cancer pain. Joseph JM; Goddard MB; Mills J; Padrun V; Zurn A; Zielinski B; Favre J; Gardaz JP; Mosimann F; Sagen J Cell Transplant; 1994; 3(5):355-64. PubMed ID: 7530113 [TBL] [Abstract][Full Text] [Related]
53. Enhancement of proliferation of intrasplenically transplanted hepatocytes in cirrhotic rats by hepatic stimulatory substance. Jiang B; Sawa M; Yamamoto T; Kasai S Transplantation; 1997 Jan; 63(1):131-5. PubMed ID: 9000674 [TBL] [Abstract][Full Text] [Related]
54. Characterization of long-term survival of syngeneic hepatocytes in rat peritoneum. Selden C; Casbard A; Themis M; Hodgson HJ Cell Transplant; 2003; 12(6):569-78. PubMed ID: 14579925 [TBL] [Abstract][Full Text] [Related]
55. Longitudinal studies on the microcirculation around the TheraCyte immunoisolation device, using the laser Doppler technique. Rafael E; Gazelius B; Wu GS; Tibell A Cell Transplant; 2000; 9(1):107-13. PubMed ID: 10784072 [TBL] [Abstract][Full Text] [Related]
56. [Use of xenogenic lyophilized hepatocytes in the treatment of acute and chronic liver diseases]. Musselius SG; Vasina NV; Gladskikh LV Anesteziol Reanimatol; 1998; (6):49-53. PubMed ID: 10050337 [TBL] [Abstract][Full Text] [Related]
58. Subnormothermic preservation maintains viability and function in a porcine hepatocyte culture model simulating bioreactor transport. van de Kerkhove MP; Hoekstra R; van Nooijen FC; Spoelstra FO; Doorschodt BM; van Wijk AC; Poyck PP; Chamuleau RA; van Gulik TM Cell Transplant; 2006; 15(2):161-8. PubMed ID: 16719049 [TBL] [Abstract][Full Text] [Related]
59. Angiopolarity: a new design parameter for cell transplantation devices and its application to degradable systems. Wintermantel E; Cima L; Schloo B; Langer R ASAIO Trans; 1991; 37(3):M334-6. PubMed ID: 1721514 [TBL] [Abstract][Full Text] [Related]
60. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Mai G; Nguyen TH; Morel P; Mei J; Andres A; Bosco D; Baertschiger R; Toso C; Berney T; Majno P; Mentha G; Trono D; Buhler LH Xenotransplantation; 2005 Nov; 12(6):457-64. PubMed ID: 16202069 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]